C-reactive Protein Testing Market Size, Share, and Growth Analysis, By Product, By Assay Type, By Detection Range, By Setting, By End User, By Disease Area, By Region - Industry Forecast 2026-2033

Global C-reactive Protein Testing Market size was valued at USD 3.6 Billion in 2024 and is poised to grow from USD 3.72 Billion in 2025 to USD 4.82 Billion by 2033, growing at a CAGR of 3.3% during the forecast period (2026-2033).

Advancements in nanotechnology and the development of point-of-care assays are driving significant growth in the global C-reactive protein (CRP) testing market. These innovations enhance specificity, sensitivity, and response times for on-site disease diagnosis and monitoring. Additionally, the escalating prevalence of inflammatory disorders, diabetes, and cancer is further fueling market expansion. The increasing incidence of conditions like endometriosis, alongside rising investments in the diagnostics sector and greater adoption of point-of-care devices, is expected to catalyze market growth. The key role of CRP testing as a vital diagnostic tool, particularly in early detection of various health conditions, underscores its importance in healthcare, indicating a robust demand trajectory for the global CRP testing market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global C-reactive Protein Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global C-reactive Protein Testing Market Segments Analysis

Global C-reactive Protein Testing Market is segmented by Product, Assay Type, Detection Range, Setting, End User, Disease Area and region. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Assay Type, the market is segmented into Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay and Immunoturbidimetric Assay. Based on Detection Range, the market is segmented into Conventional CRP and hs-CRP. Based on Setting, the market is segmented into Laboratory Testing and Point-of-Care Testing. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others. Based on Disease Area, the market is segmented into Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global C-reactive Protein Testing Market

The growth of the global C-reactive protein testing market is significantly influenced by the escalating prevalence of cardiovascular diseases and the surge in research and development efforts aimed at improving testing methodologies. As cardiovascular conditions continue to impact a substantial number of individuals, with varying degrees of severity leading to numerous fatalities, the demand for reliable diagnostic tools is intensifying. This scenario underscores the critical need for advanced C-reactive protein testing solutions, which are essential for early detection and management of inflammatory responses linked to cardiovascular health. These factors collectively contribute to the upward trajectory of the market.

Restraints in the Global C-reactive Protein Testing Market

The global C-reactive protein testing market faces several significant restraints that could hinder its growth. A prevalent lack of awareness about CRP testing, coupled with limited access to advanced technologies in various lower to medium-sized economies, is likely to impede market expansion. Furthermore, the high costs associated with testing methodologies and the substantial initial investments required for setting up the necessary infrastructure may deter potential users. These factors collectively may restrict the adoption and utilization of C-reactive protein testing solutions, ultimately affecting the overall development of the market.

Market Trends of the Global C-reactive Protein Testing Market

The Global C-reactive Protein Testing market is witnessing a significant upswing driven by a surge in awareness programs aimed at enhancing the understanding of chronic disorders and their management. Government initiatives are playing a pivotal role in promoting the importance of early diagnosis and preventative care, thereby elevating the demand for CRP testing in clinical settings. This trend is particularly pronounced in developed regions, where healthcare providers are increasingly incorporating CRP tests into routine practice. As awareness grows and healthcare systems evolve, the market is positioned for robust growth, underscoring the vital role of CRP testing in disease management and patient care.